S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

PTN Palatin Technologies Inc New

1.86

0.00 (0.00%)

Pre Market

Last Updated: 21:00:00

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

Palatin Technologies (AMEX:PTN)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Palatin Technologies Charts.

Palatin Technologies (AMEX:PTN)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Palatin Technologies Charts.

Palatin Technologies Inc News

Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024
Tuesday 30 April 2024 (1 day ago) • PR Newswire (US)

Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024
Monday 8 April 2024 (3 weeks ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
Wednesday 28 February 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Friday 16 February 2024 (2 months ago) • Edgar (US Regulatory)

Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
Thursday 15 February 2024 (2 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024
Friday 9 February 2024 (3 months ago) • PR Newswire (US)

Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
Monday 5 February 2024 (3 months ago) • PR Newswire (US)

Form 8-K - Current report
Friday 2 February 2024 (3 months ago) • Edgar (US Regulatory)

More Palatin Technologies Inc News Articles

Newcrest Mining

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions